Related Experiment Video
Updated: Apr 26, 2026
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
1.8K
ILC2s and their immune checkpoints in the antitumor response
Cecilia Ciancaglini1, Silvia Santopolo1, Paola Vacca1
1Innate Lymphoid Cell Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Journal for Immunotherapy of Cancer
|April 24, 2026
Summary
Innate lymphoid cells type 2 (ILC2s) play a complex role in cancer immunity. Their involvement in antitumor responses and immunotherapy efficacy, particularly concerning immune checkpoints like PD-1, is under investigation.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Immunology
Background:
- Innate lymphoid cells type 2 (ILC2s) are key players in mucosal immunity, asthma, and tissue repair.
- The role of ILC2s in antitumor immunity is complex and context-dependent, influenced by cancer type and microenvironment interactions.
Purpose of the Study:
- To review the current understanding of ILC2s' contribution to cancer development.
- To explore the role of ILC2s in response to cancer immunotherapy targeting immune checkpoints.
Main Methods:
- Literature review of recent studies on ILC2s in cancer.
- Analysis of immune checkpoint expression (PD-1, CTLA-4) on ILC2s.
- Examination of ILC2 interactions within the tumor microenvironment.
Main Results:
- ILC2s' function in cancer immunity varies significantly across different cancer types.
- Immune checkpoint expression, including PD-1 and CTLA-4, is observed on ILC2s.
- ILC2s interact with other immune cells, modulating the antitumor response.
Conclusions:
- ILC2s have a dual role in cancer, potentially promoting or inhibiting tumor growth.
- Understanding ILC2s' interaction with immune checkpoints is crucial for developing effective cancer immunotherapies.
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:27Cytotoxic T Cells-mediated Immune Response
7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K
02:17The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
01:24T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
01:22T Cell Activation and Clonal Selection
13.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
13.6K
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K